HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM

NCT04547621 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Glioma, Malignant

Interventions

DEVICE: Radiation
DEVICE: Radiation
DRUG: Temozolomide

Sponsor

Huashan Hospital